Similar to This
Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug business: OSAKA/TOKYO -- Japanese drugmaker Shionogi will acquire U.S.-based biopharma ...
asia.nikkei.com/business/pharmaceuticals/shionogi-to-buy-us-based-intrabio-for-2bn-to-expand-rare-disease-drug-business
Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug ...
Regeneron drug for disease that causes dangerous bone growth earns FDA approval: Patients with FOP form bone where it shouldn't be. The drug, Pasatru ...
statnews.com/2026/08/19/regeneron-fop-garetosmab-fda-approval-pasatru/
Regeneron drug for disease that causes dangerous bone growth earns FDA ...
Nursing Practice in Rare Disease: Care Coordination: How can you reduce fragmentation of care, shorten diagnostic journeys, improve outcomes for patients ...
medscape.org/viewarticle/nursing-practice-rare-disease-care-coordination-2025a1000uqe
Nursing Practice in Rare Disease: Care Coordination
Nursing Practice in Rare Disease: Care Coordination: How can you reduce fragmentation of care, shorten diagnostic journeys, improve outcomes for patients ...
medscape.org/viewarticle/nursing-practice-rare-disease-care-coordination-2025a1000uqe
Nursing Practice in Rare Disease: Care Coordination
Study of rare bone disease reaches important milestone: Progress by a UMass Chan Medical School researcher in developing a gene therapy for a rare ...
medicalxpress.com/news/2022-10-rare-bone-disease-important-milestone.html
Study of rare bone disease reaches important milestone